Navigation Links
FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
Date:4/15/2008

- Phase II study extension shows 68-73% of patients with multiple sclerosis remained relapse-free after three years of treatment with oral FTY720 - New data demonstrate 89% of patients free from active brain lesions - the

injury caused by MS - three years after starting treatment - MS, a devastating disease causing progressive disability, affects 2.5

million people worldwide including many young adults

- FTY720 regulatory filings planned before end of 2009 in US and EU

EAST HANOVER, N.J., April 15 /PRNewswire-FirstCall/ -- The investigational oral therapy FTY720 (fingolimod) continues to demonstrate sustained benefits in patients with multiple sclerosis (MS) after three years of treatment, according to new clinical data presented today from an ongoing Phase II study extension.

Results showed that 73% of patients who began the study on FTY720 5 mg remained free from relapses after three years, and 68% of those who began the study on FTY720 1.25 mg remained relapse-free. The figures after two years of treatment were 77% and 75% respectively. On the basis of comparable efficacy and a better safety profile, all patients have been transferred to FTY720 1.25 mg in the study extension.

The 36-month data also showed an average annualized relapse rate of 0.20, equivalent to one relapse in five years, while 89% of patients were free of the active brain lesions characteristic of MS as measured by magnetic resonance imaging (MRI) three years after starting treatment.

The results were presented at the 60th annual meeting of the American Academy of Neurology (AAN) in Chicago, USA.

"These new data demonstrate the exciting potential for FTY720 to reduce relapse rates in MS patients with a convenient once-daily pill," said Professor Giancarlo Comi, Professor of Neurology at the University Vita-Salute San Raffaele in Milan, Italy. "An effective oral treatment would be a significant breakthrough in the managemen
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
2. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
3. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
4. Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
5. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
6. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
7. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
8. Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
9. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
10. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
11. ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., Dec. 3 Pharmacyclics, ... focused on developing and commercializing innovat...ne mediated diseases and cancer, today announced t... Tuesday, December 8, 2009 at 11:00am Eastern Time... discuss clinical data regarding its HDAC Program ...
(Date:12/3/2009)...OLM, Denmark and SAN DIEGO, California, December 3... Inhibits miR-122, a microRNA Important for,Hepati...ucing Hepatitis C,Virus in the Bloodstream in Chim...Virus , - SPC3649 Demonstrates Efficacy W... Adverse Events in the Treated Animals - Signaling...
(Date:12/3/2009)...., Dec. 3 Cumberland Ph...ay that data from a recent clinical trial for Cald... treatment for pain and fever, will be presented a...acists (ASHP) Midyear Clinical Meeting in Las Vega...e displayed in a poster presentation on Monday, De...
Breaking Medicine Technology:Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 2New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 3RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 1RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 2Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 1Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 2Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 3Vinpower Digital Announces Industry 26apos 3Bs First Complete Labelflash Standalone DVD Publishing System 55857 1Vinpower Digital Announces Industry 26apos 3Bs First Complete Labelflash Standalone DVD Publishing System 55857 2Vinpower Digital Announces Industry 26apos 3Bs First Complete Labelflash Standalone DVD Publishing System 55857 3
..., June 19 Kendle (Nasdaq: KNDL ), a,leading glob...O), today,announced that several of its experts wi...ation (DIA) 44th Annual Meeting. The meeting is sc...tion and Exhibition Center in,Boston, Mass. Kendle...l,development industry, including EDC, biomarkers,...
...enn., June 19 Accelerated Community Oncology,Rese...cology-focused CRO,and research network; Guardian ...logy-focused data warehouse at the 44th Annual DIA...://www.newscom.com/cgi-bin/prnh/20071112/CLM151LOG...ntract Research Organization,(CRO) exceeded perfor...
Other Medicine Technology:Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 2Kendle Experts to Present at the Drug Information Association 44th Annual Meeting 3ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting 2
(Date:12/4/2009)... , SEATTLE, Dec. 4 The Nationa...ltiple-year contract to Fred Hutchinson Cancer Res...of its Cancer Information Service Contact Center. ...hinson Center - nearly tripling the size of its cu... is fully operational, which is scheduled for Marc...
(Date:12/4/2009)... Pure Power Mouthguard (PPM) - ce...y with effective dental treatment and options , ...ember 4, 2009 -- Miami dentist Dr. H.A. Nassery ...vely treating dental problems in young athletes an...He successfully diagnosed and treated Ashley Kimme...
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ ...ion of American Physicians and Surgeons (AAPS): , ... 10:45 am,PLACE: Grand Hyatt ...NW, Renwick Room (lower level 2...15 states announce, opposition ...
(Date:12/4/2009)... InhibOx, a leading developer of...g discovery, has joined forces with MolPort, an in...on developing rare chemical trading platform and b.... Now we provide this database and its updates to ...porate it into the virtual screening procedures. O...
(Date:12/4/2009)... The renowned Center for mind-bod...ffering the only natural immuno-boosting herbal su...of Ayurveda. , San Diego,...e of unprecedented illness due to factors such as ...strain millions of people around the world are loo...
Breaking Medicine News(10 mins):Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Miami Dentist Dr. H.A. Nassery Treats Local Teen Golf Star and Helps Improve Her Performance 2Health News:State Legislators in D.C. To Blast Senate Healthcare Bill at News Conference; Say Tramples States' Rights, and Saddles with Massive Medicaid Bills; Push Bills to Block Federal Mandates 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:The Chopra Center for Wellbeing Launches Vedamune: An Ayurvedic Supplement to Support The Immune System 2
...ll today said Pennsylvania must provide access to ...and that it can be done while still ensuring,that ...able to affordably,practice in the state. The Gove...l Pennsylvanians - or CAP - nearly 11 months,ago, ...
... 15,000 - 20,000,members, ATLANTA, Dec. 4 Kaiser...ek, to accommodate its growing membership in,DeKal... cutting and,dedication ceremony for the new Stone...oner Lee May, Rockdale,County Commissioner JaNice ...
...votal Study and Begin Europe...ted Information on its Investors, MENLO PARK, Cal...opment of devices for the percutaneous repair of c...rs including,Delphi Ventures, New Enterprise Assoc...
...ed trials later contradict them , TUESDAY, Dec. 4 ...adictory evidence from randomized trials, refuted ...t in scientific circles, Greek researchers claim.... experts the "gold standard" for research. , But i...
...ids don,t lessen symptoms , , TUESDAY, Dec...oids work no better than a placebo in combating si...biotics are probably not as effective as have been...edical care at the University of Southampton. "Pat...
...ular wisdom that plump babies are happy babies. A ... who had a low birth weight are more likely to exp...e found that even people who had just mild or mode... of the University of Albertas School of Public He...
Other Medicine News:Health News:Governor Rendell Says Funds Are Within Reach to Cover the Uninsured, Continue Mcare Abatement Program 2Health News:Governor Rendell Says Funds Are Within Reach to Cover the Uninsured, Continue Mcare Abatement Program 3Health News:Governor Rendell Says Funds Are Within Reach to Cover the Uninsured, Continue Mcare Abatement Program 4Health News:Kaiser Permanente Opens 15th Medical Facility in Georgia 2Health News:UPDATED: Evalve(R) Completes $60 Million Series D Financing 2Health News:UPDATED: Evalve(R) Completes $60 Million Series D Financing 3Health News:Observational Studies Often Overshadow Clinical Research 2Health News:Observational Studies Often Overshadow Clinical Research 3Health News:Sinusitis Treatments Found Ineffective 2Health News:Sinusitis Treatments Found Ineffective 3Health News:Smaller babies more prone to depression, anxiety later on 2
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: